Fitusiran meets primary endpoint in ATLAS-A/B trial Presented ByDr Alok Srivastava, Christian Medical College Vellore, India TrialPhase 3, ATLAS-A/B ConferenceASH 2021 TypePeer-reviewed article 4 February 2022 10:50
ASH 2021 Highlights Podcast Presented ByDr Rachel Giles, Medicom ConferenceASH 2021 4 January 2022 08:00